Publication: Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up
dc.contributor.author | Bektas, Gonca | |
dc.contributor.author | YEŞİL, GÖZDE | |
dc.contributor.author | Ozkan, Melis Ulak | |
dc.contributor.author | Yildiz, Edibe Pembegul | |
dc.contributor.author | Uzunhan, Tugce Aksu | |
dc.contributor.author | Caliskan, Mine | |
dc.contributor.institutionauthor | YEŞİL, GÖZDE | |
dc.date.accessioned | 2019-11-17T23:41:42Z | |
dc.date.available | 2019-11-17T23:41:42Z | |
dc.date.issued | 2018-08-01 | |
dc.description.abstract | Background: Vanishing white matter disease is a heterogeneous disorder caused by mutation in one of the five genes encoding subunits of the eukaryotic initiation factor eIF2B. It is a heterogeneous disorder due to phenotypic variation and a clear genotype-phenotype correlation could not be established so far. We describe a novel mutation in the EIF2B5 gene by analyzing the clinical phenotype and the progression of brain lesions for 10 years. | |
dc.identifier.citation | Bektas G., YEŞİL G., Ozkan M. U. , Yildiz E. P. , Uzunhan T. A. , Caliskan M., -Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up-, CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.171, ss.190-193, 2018 | |
dc.identifier.pubmed | 29933199 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12645/10344 | |
dc.language.iso | en | |
dc.title | Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | 4382a5cb-2bd6-4434-984f-39557ff27774 | |
local.indexed.at | PubMed | |
relation.isAuthorOfPublication | b653abbc-327a-4b3b-a227-f3344d8d6b70 | |
relation.isAuthorOfPublication.latestForDiscovery | b653abbc-327a-4b3b-a227-f3344d8d6b70 |